Royal Bank of Canada Raises Tenet Healthcare (NYSE:THC) Price Target to $136.00

Tenet Healthcare (NYSE:THC – Free Report) had its target price lifted by Royal Bank of Canada from $109.00 to $136.00 in a report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. THC has been the subject of a number of other reports. UBS Group upped […]

Related Keywords

United States ,Canada ,Richardj Mark , ,Securities Exchange Commission ,Tenet Healthcare ,Royal Bank ,Bleakley Financial Group ,Tenet Healthcare Corporation ,Vanguard Group Inc ,First Eagle Investment Management ,Tenet Healthcare Company Profile ,Td Asset Management Inc ,Wells Fargo Company ,Free Report ,Wells Fargo ,Truist Financial ,Get Free Report ,Exchange Commission ,Director Richard ,Investment Management ,Eagle Investment Management ,Financial Group ,Management Inc ,Healthcare Corporation ,Hospital Operations ,Tenet Healthcare Daily ,Nyse Thc ,Thc ,Medical ,88033g40 ,Boost Price Target ,Royal Bank Of Canada ,